Kurs
+2,24%
Kurs
+2,24%
Open
31,30
High
32,40
Low
31,20
Close
32,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
14,2 MNOK
Likviditet
14,2 MNOK
Rel. mcap
2,06%
Antal aktier
444 750
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2025-11-06 | N/A | Kvartalsrapport 2025-Q3 |
2025-08-14 | N/A | Kvartalsrapport 2025-Q2 |
2025-05-27 | N/A | Årsstämma |
2025-05-08 | N/A | Kvartalsrapport 2025-Q1 |
2025-02-13 | N/A | Bokslutskommuniké 2024 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-22 | - | Kvartalsrapport 2024-Q2 |
2024-06-26 | - | Årsstämma |
2024-06-06 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-01 | - | Bokslutskommuniké 2023 |
2023-11-02 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-06-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2023-06-06 | - | Årsstämma |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-08-18 | - | Kvartalsrapport 2022-Q2 |
2022-06-23 | - | Årsstämma |
2022-05-27 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-01-27 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2021-05-20 | - | Årsstämma |
2021-04-22 | - | Kvartalsrapport 2021-Q1 |
2021-01-28 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-08-19 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2020-05-14 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-01-30 | - | Bokslutskommuniké 2019 |
2020-01-06 | - | Extra Bolagsstämma 2020 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-16 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2019-05-15 | - | Årsstämma |
2019-04-30 | - | Kvartalsrapport 2019-Q1 |
2019-01-30 | - | Bokslutskommuniké 2018 |
2018-10-18 | - | Kvartalsrapport 2018-Q3 |
2018-08-16 | - | Kvartalsrapport 2018-Q2 |
2018-05-09 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2018-05-07 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-01 | - | Bokslutskommuniké 2017 |
2017-10-19 | - | Kvartalsrapport 2017-Q3 |
2017-08-17 | - | Kvartalsrapport 2017-Q2 |
2017-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2017-05-11 | - | Årsstämma |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-02-02 | - | Bokslutskommuniké 2016 |
2016-10-26 | - | Kvartalsrapport 2016-Q3 |
2016-08-17 | - | Kvartalsrapport 2016-Q2 |
2016-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2016-05-11 | - | Årsstämma |
2016-04-19 | - | Kvartalsrapport 2016-Q1 |
2016-02-11 | - | Kapitalmarknadsdag 2016 |
2016-02-11 | - | Bokslutskommuniké 2015 |
2015-11-03 | - | Kvartalsrapport 2015-Q3 |
2015-08-13 | - | Kvartalsrapport 2015-Q2 |
2015-05-13 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2015-05-12 | - | Årsstämma |
2015-05-05 | - | Kvartalsrapport 2015-Q1 |
2015-02-17 | - | Bokslutskommuniké 2014 |
2014-11-05 | - | Kvartalsrapport 2014-Q3 |
2014-08-13 | - | Kvartalsrapport 2014-Q2 |
2014-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2014-05-14 | - | Årsstämma |
2014-04-30 | - | Kvartalsrapport 2014-Q1 |
2014-02-14 | - | Bokslutskommuniké 2013 |
2013-11-01 | - | Kvartalsrapport 2013-Q3 |
2013-08-09 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | Kapitalmarknadsdag 2013 |
2013-05-28 | - | X-dag ordinarie utdelning |
2013-05-27 | - | Årsstämma |
2013-05-07 | - | Kvartalsrapport 2013-Q1 |
2013-02-01 | - | Extra Bolagsstämma 2013 |
2013-01-07 | - | Bokslutskommuniké 2012 |
2012-11-06 | - | Kvartalsrapport 2012-Q3 |
2012-08-10 | - | Kvartalsrapport 2012-Q2 |
2012-05-07 | - | Årsstämma |
2012-05-07 | - | Kvartalsrapport 2012-Q1 |
2012-05-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
2012-02-21 | - | Bokslutskommuniké 2011 |
2011-11-08 | - | Kvartalsrapport 2011-Q3 |
2011-08-10 | - | Kvartalsrapport 2011-Q2 |
2011-05-13 | - | Årsstämma |
2011-05-13 | - | Kvartalsrapport 2011-Q1 |
2011-05-12 | - | X-dag ordinarie utdelning |
2011-02-17 | - | Bokslutskommuniké 2010 |
2010-11-12 | - | Kvartalsrapport 2010-Q3 |
2010-08-10 | - | Kvartalsrapport 2010-Q2 |
2010-05-11 | - | Kvartalsrapport 2010-Q1 |
2010-05-04 | - | Årsstämma |
2010-03-03 | - | Bokslutskommuniké 2009 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-06-17 08:41:52
Tromsø, Norway, 17. June 2020 - Biotec Pharmacon (OSE: BIOTEC) announces it has officially rebranded to ArcticZymes Technologies. As previously announced and decided by the Annual General Meeting, Biotec Pharmacon ASA has formally changed its name to ArcticZymes Technologies ASA. The new name is formally registered with Brønnøysundregistrene and will trade under the new ticker "AZT" over the next days. The name change will also coincide with the unveiling of a new brand identity, a new corporate logo and an updated website (Arcticzymes.com) The company has undergone a significant transformation over the last year with the ArcticZymes subsidiary representing the core business and profitable part of the company. The new brand reflects the company's future identity and strategy to focus on growing its enzymes business via a combination of organic and inorganic initiatives. Longer-term, the company has ambitions to expand into other technologies beyond enzymes. ArcticZymes is a global leader in supplying best-in-class enzyme technologies to commercial partners who develop therapeutics, In vitro Diagnostics (IVD) and molecular research kit products. The success of the enzymes business has been a result of forging long-term commercial partnerships with its customers as a reliable and trusted supplier. Hence, incorporating ArcticZymes into the new corporate brand name is instrumental in recognizing the strong and positive brand positioning the company has achieved in the market. The two subsidiaries, ArcticZymes AS and Biotec BetaGlucans AS will remain. However, the future direction and activities of the group will be very different than earlier with the enzyme business being at the forefront. ArcticZymes Technologies ASA, CEO, Jethro Holter said: "ArcticZymes Technologies has arrived and the company enters a new era. Our future is all about enzymes. With this, the company needed a new image and identity that reflects its foundations and recognizes what is core at driving the future value of the business. I trust our customers, partners and investors are as inspired as us about embarking on a new chapter in the company's history." -ENDS- For more information, please contact: ArcticZymes Technologies Jethro Tel: +47 46 85 91 46Email: Jethro.holter@arcticzymes.com Holter, CEO Børge Tel: +47 95 29 01 87Email: borge.sorvoll@arcticzymes.com Sørvoll, CFO About ArcticZymes Technologies ASA ArcticZymes Technologies is a Norwegian life sciences company focused on premium and novel enzyme as well as immunomodulating beta-glucan technology. The ArcticZymes Technologies Group is creating value from innovation in life science markets via its subsidiaries, ArcticZymes and Biotec BetaGlucans. Its technologies capitalize on more than three decades of world-class research at the Arctic University of Tromsø to offer niche and high-tech products in several biotech segments. ArcticZymes represents its core business where it develops, manufactures and commercializes novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics. Biotec BetaGlucans represents a non-core business where it produces and markets immunomodulating beta-glucans addressing several market areas. Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec] ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre. ArcticZymes Technologies' unique IP and capabilities are protected via a large portfolio of patents around both enzyme and beta-glucan products. For more information, please visit the website: www.arcticzymes.com.